Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

4-MeO-Butyrfentanyl

This article is a stubmissing:
Subjective Effects
Pharmacology
Interactions
Tolerance
Legality
4-MeO-Butyrfentanyl molecule structure4-MeO-Butyrfentanyl molecule structure
Psychoactive Class
Chemical Class

4-MeO-Butyrfentanyl is a rare synthetic opioid and analogue of fentanyl, distinct from the related compound butyrfentanyl. It is classified as a research chemical with habit-forming properties. Extremely limited information exists regarding its pharmacology, safety profile, and appropriate dosing parameters. As with other fentanyl analogues, overdose carries a significant risk of respiratory depression. Extreme caution is strongly advised, and it should not be combined with other stimulants or depressants.

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Reliable dosage data for this compound remains extremely scarce, and any figures should be treated with considerable caution.

Duration

After Effects1-2 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Addiction & Dependence

Psychological

Classified as habit-forming. Very limited information is available due to the rarity of this substance.

Toxicity

Respiratory

As an opioid, overdose may result in respiratory depression.

History & Culture

4-MeO-Butyrfentanyl is a rare synthetic opioid belonging to the fentanyl analogue class of compounds. The substance has received minimal documentation in both scientific literature and online harm reduction communities, and its precise history of synthesis and development remains poorly documented. It should be distinguished from the related compound butyrfentanyl, which has been more extensively characterized.

Legality

Legality not written up yet

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the 4-MeO-Butyrfentanyl article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.